Anzeige
Mehr »
Login
Sonntag, 16.05.2021 Börsentäglich über 12.000 News von 658 internationalen Medien
Analysten vergeben Bestnoten und hohe Kursziele bis zu 13,50! Das ist der Grund!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PJN7 ISIN: US1920101060 Ticker-Symbol: 32W 
Tradegate
13.05.21
11:32 Uhr
13,700 Euro
-0,400
-2,84 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
CODIAK BIOSCIENCES INC Chart 1 Jahr
5-Tage-Chart
CODIAK BIOSCIENCES INC 5-Tage-Chart
RealtimeGeldBriefZeit
14,50014,90015.05.
14,90015,00014.05.

Aktuelle News zur CODIAK BIOSCIENCES Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrAs Codiak enters 'next phase of growth,' Jennifer Wheler steps into CMO role; Mark Timney lines up his second CEO opportunity after Purdue Pharma reign2
MoCodiak names Jennifer Wheler as chief medical officer5
27.04.Codiak BioSciences, Inc.: Codiak to Present Preclinical Data Demonstrating Broad Potential Applications for Engineered Exosomes at the American Society ...4
CODIAK BIOSCIENCES Aktie jetzt für 0€ handeln
22.04.Codiak BioSciences, Inc.: Data from Codiak's exoSTING Preclinical Development Program for the Treatment of Solid Tumors Published in the Nature Research ...11
10.04.AACR roundup: Arcus rolls out PhI/II data on adenosine blocker for CRC; Codiak's engineered exosome for IL-12 shows early promise1
10.04.Codiak BioSciences, Inc.: Codiak Presents Data at AACR 2021 Demonstrating Potential of Engineered Exosomes to Enhance the Therapeutic Index of Well-Validated ...5
08.04.Codiak BioSciences, Inc. - 8-K, Current Report2
17.03.Codiak BioSciences, Inc. - S-8, Securities to be offered to employees in employee benefit plans2
17.03.Codiak BioSciences, Inc. - 10-K, Annual Report3
17.03.Codiak BioSciences, Inc. - 8-K, Current Report1
17.03.Codiak BioSciences, Inc.: Codiak BioSciences Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Progress1
10.03.Codiak BioSciences, Inc.: Codiak to Present Data from Two Novel Engineered Exosome Therapeutic Candidate Programs at the American Association for Cancer ...2
08.03.Codiak BioSciences, Inc. - 8-K, Current Report3
17.02.Codiak BioSciences, Inc.: Codiak Announces Closing of $66.4 Million Public Offering, Including Full Exercise of Underwriters' Option4
17.02.Codiak: Pioneering Engineered Exosomal Drug Delivery3
12.02.Codiak prices equity offering at $213
12.02.Codiak BioSciences, Inc.: Codiak Announces Pricing of $57.8 Million Public Offering of Common Stock3
09.02.Codiak BioSciences, Inc.: Codiak Announces Proposed Public Offering of Common Stock-
04.02.Codiak BioSciences, Inc. - 8-K, Current Report5
26.01.Codiak BioSciences, Inc. - 8-K, Current Report4
Seite:  Weiter >>
29 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1